Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: The study was conducted according to the O.E.C.D. test guideline no. 429 with GLP compliance.

Data source

Reference
Reference Type:
publication
Title:
Unnamed
Year:
2008
Report date:
2008

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
Deviations:
not specified
GLP compliance:
yes
Remarks:
with test substance characterization.
Type of study:
mouse local lymph node assay (LLNA)

Test material

Constituent 1
Chemical structure
Reference substance name:
p-tert-butylphenyl 1-(2,3-epoxy)propyl ether
EC Number:
221-453-2
EC Name:
p-tert-butylphenyl 1-(2,3-epoxy)propyl ether
Cas Number:
3101-60-8
Molecular formula:
C13H18O2
IUPAC Name:
2-[(4-tert-butylphenoxy)methyl]oxirane
Constituent 2
Reference substance name:
p-tert-butylphenyl-1-(2,3)-epoxypropyl ether
IUPAC Name:
p-tert-butylphenyl-1-(2,3)-epoxypropyl ether
Constituent 3
Reference substance name:
Oxirane, 2-((4-(1,1-dimethylethyl)phenoxy)methyl)-
IUPAC Name:
Oxirane, 2-((4-(1,1-dimethylethyl)phenoxy)methyl)-
Test material form:
other: Liquid at room temperature.
Details on test material:
As per IUCLID5 Sections 1.1. 1.2. and 4.1.

In vivo test system

Test animals

Species:
mouse
Strain:
CBA
Sex:
female
Details on test animals and environmental conditions:
The mice were purchased from Harlan Winkelmann GmbH, Borchen, Germany. The animals were housed in Makrolon type I cages in fully air- conditioned rooms in which a central air-conditioning system ensured a temperature in the range of 20—24 °C and a relative humidity in the range of 30—70%. The illumination period was as follows: 12 h light (6.00 a.m.—6.00 p.m.) and 12 h darkness (6.00 p.m.—6.00 a.m.). Tap water and diet was provided ad libitum.

Study design: in vivo (LLNA)

Vehicle:
other: Acetone
Concentration:
The test substance was applied at concentrations of 0.1, 0.3 and 1.0 % v/v
No. of animals per dose:
6
Details on study design:
For the study, groups of 6 female CBA mice were treated with different concentrations of the test substances in acetone or with acetone alone (vehicle control). Twenty five microliter per ear of the respective test substance preparation was applied to the dorsum of both ears for three consecutive days. The control group was treated solely with 25 uL per ear of the vehicle acetone.

Three days after the last application, the mice were injected intravenously (i.v.) with 20 uCi of [3H1-thymidine in 250 uL of sterile saline into a tail vein. About 5 h after the [3H1-thymidine injection, the mice were sacrificed and the auricular lymph nodes on both sides were removed and the weight of each animal’s pooled lymph nodes was determined. Lymph node response was evaluated by measuring the cellular content and [3H]-thymidine incorporation into lymph node cells (indicators of cell proliferation). To this end, single cell suspensions were prepared from the pooled lymph nodes of each animal as soon as possible after dissection by carefully passing the lymph nodes through an iron mesh (mesh size 200 l.tm) into 6 mL of phosphate-buffered physiological saline. Cell Suspensions were washed twice with phosphate buffered saline (PBS) and precipitated with 5% trichloroacetic acid (TCA). Each precipitate was transferred to scintillation fluid and incorporation of [3H}-thymi- dine into the cells was measured in a beta-scintillation counter.
Positive control substance(s):
hexyl cinnamic aldehyde (CAS No 101-86-0)
Statistics:
For cell counts, [3H]-thymidine incorporation and lymph node weights the WILCOXON test was applied.

Results and discussion

Positive control results:
Positive Control % Concentration Stimulation Index
_________________________________________________________
3 4.56
10 6.63
30 9.86
_________________________________________________________

In vivo (LLNA)

Resultsopen allclose all
Parameter:
SI
Remarks on result:
other: see Remark
Remarks:
Test Substance % Concentration Stimulation Index ________________________________________________________ 0.1 1.36 0.3 1.68 1.0 14.2 ________________________________________________________
Parameter:
other: disintegrations per minute (DPM)
Remarks on result:
other: No data presented.

Applicant's summary and conclusion

Interpretation of results:
sensitising
Remarks:
Migrated information Criteria used for interpretation of results: other: Authors of the piblication.
Conclusions:
Inducing a Stimulation Index of 14.2 at a concentration of 1.0 % v/v the test substance is considered to be a Strong skin sensitiser. The estimated EC3 value is 0.4% v/v.
Executive summary:

The test substance, p-tert-butylphenyl-1 -(2,3 -epoxy)propyl ether was accessed for skin sensitization potential in an O.E.C.D. test guideline no. 429 LLNA study. Inducing a Stimulation Index of 14.2 at a concentration of 1.0 % v/v the test substance is considered to be a Strong skin sensitiser.